Regulate the Price of All Drugs Act
To establish fair prices for prescription drugs, and for other purposes.
HB9040, known as the Regulate the Price of All Drugs Act, aims to create a system for setting fair prices for prescription drugs. This bill was introduced on May 26, 2026, by Brad Sherman, a Democrat, who is the primary sponsor. The bill seeks to address the rising costs of prescription medications, which can be a significant burden for many individuals and families.
If passed, the bill would impact both pharmaceutical companies and consumers. It would require drug manufacturers to adhere to a pricing structure that is deemed fair and reasonable, potentially lowering costs for patients. This could make medications more affordable for everyone, especially for those who rely on prescription drugs for chronic conditions or other ongoing health needs.
Currently, HB9040 is in its initial stages. It has been introduced in the House and referred to the Committee on Energy and Commerce, as well as to the Committees on the Judiciary and Financial Services. These committees will review the bill's provisions and decide on further actions, which could include holding hearings or making recommendations for changes.
